Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion

Shares of Sino Biopharmaceutical (HK:1177) climbed on Wednesday after the Chinese pharmaceutical company announced a major licensing agreement with AstraZeneca (ST:AZN) and expanded its strategic commercial partnership...